Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV002227594 | SCV002506631 | uncertain significance | FBRSL1-associated neurodevelopmental syndrome | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004694175 | SCV005192058 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004917784 | SCV005583107 | uncertain significance | not specified | 2024-08-27 | criteria provided, single submitter | clinical testing | The c.2939C>T (p.A980V) alteration is located in exon 17 (coding exon 17) of the FBRSL1 gene. This alteration results from a C to T substitution at nucleotide position 2939, causing the alanine (A) at amino acid position 980 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |